Transaction in Own Shares

Summary by AI BETAClose X

On September 16, 2025, GSK plc announced the purchase of 253,331 of its own ordinary shares, priced between 1,476.00p and 1,505.50p, with a volume-weighted average price of 1,482.92p per share. These shares, with a nominal value of 31¼ pence each, will be held as treasury shares as part of an existing buyback program. Since June 4, 2025, GSK has bought back 28,894,340 ordinary shares. Following this transaction, GSK holds 247,028,723 ordinary shares in treasury, representing 6.07 percent of voting rights, and has 4,068,374,245 ordinary shares in issue excluding treasury shares; the total number of voting rights is 4,068,374,245. All purchases were executed on the London Stock Exchange.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings